Perioperative platelet and monocyte activation in patients with critical limb ischemia

Journal of Vascular Surgery

Volumn 52, Issue 3, 2010, Pages 697-703

  Burdess, Anne ^a   Nimmo, Alastair F ^a   Campbell, Neil ^a   Harding, Scott A ^b   Garden, O J ^a   Dawson, A Raymond ^c   Newby, David E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CD11B ANTIGEN; CD40 ANTIGEN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PADGEM PROTEIN; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; ITGAM PROTEIN, HUMAN;

ACUTE HEART INFARCTION; ADULT; ARTHROPLASTY; ARTICLE; BYPASS SURGERY; CELL ACTIVATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FLOW CYTOMETRY; HUMAN; IN VIVO STUDY; INTERMITTENT CLAUDICATION; LIMB ISCHEMIA; MONOCYTE; OBSERVATIONAL STUDY; PERIOPERATIVE PERIOD; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; UNITED KINGDOM; AGED; BLOOD; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; CRITICAL ILLNESS; FEMALE; ISCHEMIA; LEG; MALE; MEMBRANE MICROPARTICLE; METABOLISM; MIDDLE AGED; THROMBOCYTE; VASCULAR SURGERY; VASCULARIZATION;

AGED; ANTIGENS, CD11B; ANTIGENS, CD40; BIOLOGICAL MARKERS; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; CHI-SQUARE DISTRIBUTION; CRITICAL ILLNESS; CROSS-SECTIONAL STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; ISCHEMIA; LOWER EXTREMITY; MALE; MIDDLE AGED; MONOCYTES; P-SELECTIN; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; SCOTLAND; VASCULAR SURGICAL PROCEDURES;

EID: 77956364658     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.04.024     Document Type: Article

References (30)

1. M.H. Criqui, R.D. Langer, A. Fronek, H.S. Feigelson, M.R. Klauber, and T.J. McCann Mortality over a period of 10 years in patients with peripheral arterial disease N Engl J Med 326 1992 381 386
2. A.J. Lee, J.F. Price, M.J. Russell, F.B. Smith, M.C.W. van Wijk, and F.G.R. Fowkes Improved prediction of fatal myocardial infarction using the ankle brachial index in addition to conventional risk factors: the Edinburgh Artery Study Circulation 110 2004 3075 3080
3. A.M. O'Hare, R. Katz, M.G. Shlipak, M. Cushman, and A.B. Newman Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study Circulation 113 2004 388 393
4. S.D. Hobbs, M. Yapanis, P.J. Burns, A.B. Wilmink, A.W. Bradbury, and D.J. Adam Peri-operative myocardial injury in patients undergoing surgery for critical limb ischaemia Eur J Vasc Endovasc Surg 29 2005 301 304
5. L.J. Kim, E.A. Martinez, N. Faraday, T. Dorman, L.A. Fleisher, and B.A. Perler Cardiac Troponin I predicts short-term mortality in vascular surgery patients Circulation 106 2002 2366 2371
6. G. Landesburg, V. Shatz, I. Akopnik, Y.G. Wolf, M. Mayer, and Y. Berlatzky Association of cardiac troponin, CK-MB, and postoperative myocardial ischaemia with long term survival after major vascular surgery J Am Coll Cardiol 42 2003 1547 1554
7. M.E. Bertrand, M.L. Simoons, K.A.A. Fox, L.C. Wallentin, C.W. Hamm, and E. McFadden Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Eur Heart J 23 2002 1809 1840
8. J.E. Freedman, and J. Loscalzo Platelet-monocyte aggregates: Bridging thrombosis and inflammation Circulation 105 2002 2130 2132
9. C. Urbich, and S. Dimmeler CD40 and vascular inflammation Can J Cardiol 20 2004 681 683
10. M. Rizvi, D. Pathak, J.E. Freedman, and S. Chakrabarti CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease Trends in Molecular Medicine 14 2008 530 538
11. F. Neuman, N. Marx, M. Gawaz, K. Brand, I. Ott, and C. Rokitta Induction of cytokine expression in leucocytes by binding of thrombin-stimulated platelets Circulation 95 1997 2387 2394
12. U. Schonbeck, and P. Libby CD40 signalling and plaque instability Circ Res 89 2001 1092 1103
13. F. Mach, U. Schonbeck, G.K. Sukhova, E. Atkinson, and P. Libby Reduction of atherosclerosis in mice by inhibition of CD40 signalling Nature 394 1998 2003
14. Y. Huo, A. Schober, S.B. Forlow, D.F. Smith, M.C. Hyman, and S. Jung Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E Nat Med 9 2003 61 67
15. S.A. Harding, D.H. Josephs, N.L.M. Cruden, J.N. Din, P.J. Twomey, and K.A. Fox Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers Circulation 109 2004 1926 1929
16. S.A. Harding, A.J. Sommerfield, J. Sarma, P.J. Twomey, D.E. Newby, and B.M. Frier Increased CD40 ligand and platelet monocyte aggregates in patients with type 1 diabetes mellitus Atherosclerosis 176 2004 321 325
17. J. Sarma, C.A. Laan, S. Alam, A. Jha, K.A. Fox, and I. Dransfield Increased platelet binding to circulating monocytes in acute coronary syndromes Circulation 105 2002 2166 2171
18. P.A. Gurbel, K.P. Bliden, K. Guyer, P.W. Cho, K.A. Zaman, and R.P. Kreutz Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study J Am Coll Cardiol 10 2005 1820 1826
19. K. Cassar, P. Bachoo, I. Ford, M. Greaves, and J. Brittenden Platelet activation in increased in peripheral arterial disease J Vasc Surgery 38 2003 99 103
20. P.A. Robless, D. Okonko, P. Lintott, A.O. Mansfield, D.P. Mikhailidis, and G.P. Stansby Increased platelet aggregation and activation in peripheral arterial disease Eur J Vasc Endovasc Surg 25 2003 1622
21. S. Rajagopalan, I. Mckay, I. Ford, P. Bachoo, M. Greaves, and J. Brittenden Platelet activation increases with the severity of peripheral arterial disease: Implications for clinical management J Vasc Surg 46 2007 485 490
22. A.D. Payne, C.I. Jones, P.D. Hayes, M.M. Thompson, N.J. London, and P.R. Bell Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy Circulation 109 2004 1476 1481
23. K. Cassar, I. Ford, M. Greaves, P. Bachoo, and J. Brittenden Randomized clinical trial of the anti-platelet effects of aspirin-clopidogrel combination vs aspirin alone after lower limb angioplasty Br J Surgery 92 2005 159 165
24. S. Rajagopalan, I. Ford, P. Bachoo, G.S. Hillis, B. Croal, and M. Greaves Platelet activation, myocardial ischaemic events and post-operative non response to aspirin in patients undergoing major vascular surgery J Thromb Haemost 5 2007 2028 2035
25. R. Sukhija, W.S. Aronow, K. Yalamanchili, N. Sinha, and S. Babu Prevalence of coronary artery disease, lower extremity peripheral arterial disease, and cerebrovascular disease in 110 men with an abdominal aortic aneurysm Am J Cardiol 94 2004 1358 1359
26. K. Cassar, R. Coull, P. Bachoo, E. Macaulay, and J. Brittenden Management of secondary risk factors in patients with intermittent claudication Eur J Vasc Endovasc Surg 26 2003 262 266
27. P. Burns, S. Gough, and A.W. Bradbury Management of peripheral arterial disease in primary care BMJ 326 2003 584 588
28. A.T. Hirsch, M.H. Criqui, D. Treat-Jacobson, J.G. Regensteiner, M.A. Creager, and J.W. Olin Peripheral arterial disease detection, awareness, and treatment in primary care JAMA 286 2001 1317 1324
29. S. Khan, M. Flather, R. Mister, N. Delahunty, G. Fowkes, and A. Bradbury Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry Eur J Vasc Endovasc Surg 33 2007 442 450
30. J.J. Belch, E.J. Topol, G. Agnelli, M. Bertrand, R.M. Califf, and D.L. Clement Critical issues in peripheral arterial disease detection and management Arch Intern Med 163 2003 884 892